- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic kidney disease
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 608KB)
Empagliflozin – November 2023
Empagliflozin: Tablet 10 mg; Jardiance®
Last updated
1 March 2024